HomeNewsBusinessIndian Railways still struggling to match pre-COVID numbers in average daily passengers

Indian Railways still struggling to match pre-COVID numbers in average daily passengers

The average railway ticket bookings recorded by IRCTC rose to 15.5-16.5 lakh a day in March and April, but fell to around 12.5 lakh in May, a railway ministry official said, against 13.2 lakh in May 2019, before the pandemic hit.

June 01, 2022 / 18:34 IST
Story continues below Advertisement
Representative Image
Representative Image

Nearly two years after the outbreak of the COVID-19 pandemic in India, Indian Railways has still not completely recovered in its passenger operations, as average daily railway ticket sales in May have been lower compared with the same period in 2019.

Senior officials from the Railway Board and Indian Railway Catering and Tourism Corporation (IRCTC) told Moneycontrol that average daily railway ticket bookings had risen significantly in March and April, but have been tapering off since.

Story continues below Advertisement

In February this year, railway ticket bookings came in at around 12 lakh, up from around 9 lakh in January, right after the outbreak of the third wave of COVID-19 in India. The average railway ticket bookings recorded by IRCTC rose to 15.5-16.5 lakh a day in March and April, but fell to around 12.5 lakh in May, a railway ministry official said, against 13.2 lakh in May 2019, before the pandemic hit.

Senior railway officials said that the fall in bookings seen right after the Holi festival period is cyclical in nature, but added that factors like slow resumption of catering services in trains, gradual restoration of train service in some states, shortage of locomotive pilots seen in some states, partial restarting of booking at stations and changing customer patterns have all contributed the fall in sales seen in May.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show